Intrinsic Value
Regulus Therapeutics Inc. (RGLS)
$2.13
-0.09 (-4.05%)
| Enterprise Value | -2,605.05 |
|---|---|
| Net Debt | -20.73 |
| Equity Value | -2,584.32 |
| Shares Outstanding | 18.96 |
| Equity Value Per Share | -136.30 |
Because investors are more interested in the value of the company’s shares alone, we’ll deduct net debt from this value to arrive at a fair value of the company’s equity. Fair Value = Enterprise Value – Debt